Purpose of Review <p>Postpartum hemorrhage (PPH) remains a leading cause of maternal mortality globally, particularly in low-resource settings. This review highlights recent advances in the prevention and management of PPH, with a focus on innovations in early detection, risk stratification, and therapeutic approaches.</p> Recent Findings <p>Recent advancements in the prevention and management of PPH have markedly enhanced maternal outcomes. Pharmacological innovations, including the application of tranexamic acid, have demonstrated potential in decreasing mortality due to bleeding when administered promptly after diagnosis of PPH. Unlike oxytocin, which requires cold-chain storage at 2–8&#xa0;°C, heat-stable carbetocin offers a thermostable alternative that maintains efficacy without refrigeration, making it especially valuable in low-resource settings where reliable cold storage is often unavailable. Non-surgical interventions, such as uterine artery embolization, and uterine tamponade/suction devices have offered essential alternatives to conventional surgical methods such as hysterectomy or compression sutures. Moreover, practice-based improvements such as risk stratification and the prompt identification of high-risk cases, quantification of blood loss and the widespread use of simulation-based training, have been adopted by many health systems. Improved hemostasis adjunct therapy and technology are on the horizon for future advancements in the field of PPH management.</p> Summary <p>Recent innovations in pharmacologic therapies, technology-assisted monitoring, and team-based care models show promise in reducing the burden of PPH. Ongoing challenges include addressing global inequities, ensuring sustainable implementation, and expanding clinical research. A coordinated effort across research, practice, and policy is essential to improve maternal outcomes worldwide.</p>